The use of transgenic mice in the investigation of transmissible spongiform encephalopathies
- PMID: 9638817
- DOI: 10.20506/rst.17.1.1079
The use of transgenic mice in the investigation of transmissible spongiform encephalopathies
Abstract
The prion, the transmissible agent that causes spongiform encephalopathies such as scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease, is believed to be devoid of nucleic acid and to be identical to PrPSc (prion protein: scrapie form), a modified form of the normal host protein PrPC (prion protein: cellular form) which is encoded by the single copy gene Prnp. The 'protein only' hypothesis proposes that PrPSc, when introduced into a normal host, causes the conversion of PrPC into PrPSc; it therefore predicts that an animal devoid of PrPC should be resistant to prion diseases. The authors generated homozygous Prnp(o/o) ('PrP knockout') mice and showed that, after inoculation with prions, these mice remained free from scrapie for at least two years while wild-type controls all died within six months. There was no propagation of prions in the Prnp(o/o) animals. Surprisingly, heterozygous Prnp(o/+) mice, which express PrPC at about half the normal level, also showed enhanced resistance to scrapie despite high levels of infectious agent and PrPSc in the brain at an early stage. After introduction of murine PrP transgenes, Prnp(o/o) mice became highly susceptible to mouse--but not to hamster--prions, while the insertion of Syrian hamster PrP transgenes rendered the mice susceptible to hamster prions but much less susceptible to mouse prions. These complementation experiments enabled the application of reverse genetics. The authors prepared animals transgenic for genes encoding PrP with amino terminal deletions of various lengths and found that PrP that lacks 48 amino proximal amino acids (which comprise four of the five octa repeats of PrP) is still biologically active.
Similar articles
-
The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.FEBS Lett. 1996 Jun 24;389(1):3-11. doi: 10.1016/0014-5793(96)00610-2. FEBS Lett. 1996. PMID: 8682199 Review.
-
Prion encephalopathies of animals and humans.Dev Biol Stand. 1993;80:31-44. Dev Biol Stand. 1993. PMID: 8270114 Review.
-
Genetic and infectious prion diseases.Arch Neurol. 1993 Nov;50(11):1129-53. doi: 10.1001/archneur.1993.00540110011002. Arch Neurol. 1993. PMID: 8105771 Review.
-
Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.Dev Biol Stand. 1991;75:55-74. Dev Biol Stand. 1991. PMID: 1686599 Review.
-
Role of the PrP gene in transmissible spongiform encephalopathies.Intervirology. 1993;35(1-4):164-75. doi: 10.1159/000150307. Intervirology. 1993. PMID: 8407244 Review.
Cited by
-
Prion disease: experimental models and reality.Acta Neuropathol. 2017 Feb;133(2):197-222. doi: 10.1007/s00401-017-1670-5. Epub 2017 Jan 13. Acta Neuropathol. 2017. PMID: 28084518 Free PMC article. Review.
-
Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory.Prion. 2016;10(1):25-40. doi: 10.1080/19336896.2015.1126038. Prion. 2016. PMID: 26890218 Free PMC article.
-
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity.PLoS Pathog. 2017 Nov 27;13(11):e1006733. doi: 10.1371/journal.ppat.1006733. eCollection 2017 Nov. PLoS Pathog. 2017. PMID: 29176838 Free PMC article.
-
Transgenesis applied to transmissible spongiform encephalopathies.Transgenic Res. 2002 Dec;11(6):547-64. doi: 10.1023/a:1021125510220. Transgenic Res. 2002. PMID: 12509129 Review.
-
Preclinical detection of variant CJD and BSE prions in blood.PLoS Pathog. 2014 Jun 12;10(6):e1004202. doi: 10.1371/journal.ppat.1004202. eCollection 2014 Jun. PLoS Pathog. 2014. PMID: 24945656 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials